2-甲酸基-2-苯基乙腈 | 5841-70-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 2-甲酸基-2-苯基乙腈
• 中文别名: 3-氧代-2-苯基丙腈
• 英文名称: phenyl(formyl)acetonitrile
• 英文别名: 3-Oxo-2-phenylpropanenitrile
• CAS: 5841-70-3
• 化学式: C₉H₇NO
• mdl: MFCD00024158
• 分子量: 145.161
• InChiKey: MGDKAIHGKFPFTO-UHFFFAOYSA-N

物化性质

• 熔点：
  157-160°C
• 沸点：
  138-140 °C(Press: 0.07 Torr)
• 密度：
  1.114±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.111
• 拓扑面积：
  40.9
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 安全说明：
  S26
• 危险类别码：
  R20/21/22
• 危险品运输编号：
  UN 3439
• 储存条件：
  -20°C

SDS

Name:	3-Hydroxy-2-phenylacrylonitrile 95+% Material Safety Data Sheet
Synonym:	2-Cyano-2-phenylacetaldehyde3-Oxo-2-phenylpropanenitril
CAS:	5841-70-3

Section 1 - Chemical Product MSDS Name:3-Hydroxy-2-phenylacrylonitrile 95+% Material Safety Data Sheet
Synonym:2-Cyano-2-phenylacetaldehyde3-Oxo-2-phenylpropanenitril

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
5841-70-3	3-Hydroxy-2-phenylacrylonitrile	95+%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5841-70-3: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 157 - 160 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C9H7NO
Molecular Weight: 145.16

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Reducing agents, oxidizing agents, bases, acids, amines.
Hazardous Decomposition Products:
Hydrogen cyanide, nitrogen oxides, carbon monoxide, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5841-70-3 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
3-Hydroxy-2-phenylacrylonitrile - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: NITRILES, SOLID, TOXIC, N.O.S.*
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
IMO
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing Group: III
RID/ADR
Shipping Name: NITRILES, TOXIC, N.O.S.
Hazard Class: 6.1
UN Number: 3276
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 5841-70-3: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 5841-70-3 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5841-70-3 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-甲酸基-2-苯基乙腈 在 盐酸 作用下， 以 乙醇 为溶剂， 生成 异丙托溴铵杂质18
  参考文献：
  名称：

  Kubiak, Bernd; Lehnig, Manfred; Neumann, Wilhelm P., Journal of the Chemical Society. Perkin transactions II, 1992, # 9, p. 1443 - 1447

  摘要：

  DOI：
• 作为产物：
  描述：

  α-甲基苯腈 在 盐酸 、 溴苯 、 dichlorobis(trimethylphosphine)palladium 、 caesium carbonate 作用下， 以 水 为溶剂， 反应 42.0h， 生成 2-甲酸基-2-苯基乙腈
  参考文献：
  名称：

  β-Amination of Saturated Nitriles through Palladium-catalyzed Dehydrogenation, 1,4-Addition, and Re-dehydrogenation

  摘要：

  在[PdCl2(PMe3)2]催化剂和溴苯的作用下，通过催化脱氢反应实现了2-芳基丙腈分子中β位上的氨化。这是首次涉及饱和腈直接脱氢的催化反应。

  DOI：

  10.1246/cl.2013.40

文献信息

• Kinase inhibitors
  申请人：Amgen Inc.

  公开号：US20040116388A1

  公开（公告）日：2004-06-17

  The invention relates to inhibitors of enzymes that bind to ATP or GTP and/or catalyze phosphoryl transfer, compositions comprising the inhibitors, and methods of using the inhibitors and inhibitor compositions. The inhibitors and compositions comprising them are useful for treating disease or disease symptoms. The invention also provides for methods of making phosphoryl transferase inhibitor compounds, methods of inhibiting phosphoryl transferase activity, and methods for treating disease or disease symptoms.

  这项发明涉及与ATP或GTP结合并/或催化磷酸转移的酶的抑制剂，包括这些抑制剂的组合物，以及使用这些抑制剂和抑制剂组合物的方法。这些抑制剂和包含它们的组合物对治疗疾病或疾病症状是有用的。该发明还提供了制备磷酸转移酶抑制剂化合物的方法，抑制磷酸转移酶活性的方法，以及治疗疾病或疾病症状的方法。
• Substituted triazinyl amide derivatives and methods of use
  申请人：——

  公开号：US20030087908A1

  公开（公告）日：2003-05-08

  The invention encompasses compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions, uses and methods for prophylaxis and treatment of cancer and angiogenesis-related disease.

  本发明包括化合物、类似物、前药及其药物可接受的盐，药物组合物，以及用于预防与治疗癌症和与血管生成相关疾病的用途和方法。
• Copper-Catalyzed<i>N</i>-Aryl-β-enaminonitrile Synthesis Utilizing Isocyanides as the Nitrogen Source
  作者：Seoksun Kim、Soon Hyeok Hong

  DOI：10.1002/adsc.201400973

  日期：2015.3.23

  A novel synthetic protocol for N‐aryl‐β‐enaminonitriles, which are useful building blocks for heterocycle synthesis, was developed using isocyanides as the nitrogen source. Using copper‐catalyzed one‐step reactions between isocyanides and benzyl cyanides under mild conditions, diverse N‐aryl‐β‐enaminonitriles could be synthesized in excellent yields and with high atom‐efficiency. N‐Alkyl‐β‐enaminonitriles

  使用异氰化物作为氮源，开发了一种新的N-芳基-β-烯胺腈合成方案，这是杂环合成的有用组成部分。使用异腈和苄基氰之间铜催化的单步反应在温和的条件，不同的下ñ -芳基- β-enaminonitriles可以以优良产率和具有高原子效率来合成。N-烷基-β-氨基腈也以高收率合成。基于机理研究和先前的报道，提出了一种涉及亚氨基-铜-铜中间体的机理。此外，我们证明了合成的N芳基-β-氨基腈可用于合成β-酮腈化合物和3-氨基吡唑。
• Synthesis of 4-amino[1] benzofuro[3,2-<i>g</i>] cinnolines
  作者：D. Ladurée、D. Florentin、M. Robba

  DOI：10.1002/jhet.5570170607

  日期：1980.9

  The synthesis of the new heterocycles, 4-amino[1]benzofuro[3,2-g]cinnolines, was accomplished by the intramolecular cyclization of the Z-configuration of cyanoarylhydrazones. The latter compounds were obtained via interaction between the diazonium salt of 3-amino-dibenzofuran and various active methylene compounds via the Japp-Klingemann reaction. The alkaline treatment of azo intermediates 4, which

  通过氰基芳基azo的Z-构型的分子内环化作用，完成了新的4-氨基[1]苯并呋喃[3,2- g ]喹啉杂环化合物的合成。后者的化合物是通过Japp-Klingemann反应通过3-氨基-二苯并呋喃的重氮盐与各种活性亚甲基化合物的相互作用而获得的。可以在缩合过程中分离出的偶氮中间体4进行碱处理，得到相应的氰基芳基hydr 5。据报道对构型和可能的异构化进行了研究。
• 2-吡啶取代脲结构小分子化合物及其合成和应用
  申请人：中国科学院上海药物研究所

  公开号：CN110818683B

  公开（公告）日：2023-04-14

  本发明涉及2‑吡啶取代脲结构小分子化合物及其合成和应用。具体地，本发明公开了式(I)所述的化合物，其对映异构体、非对映异构体、外消旋体或其混合物，或其药学上可接受的盐、水合物及溶剂合物及其制备方法和在制备ASK1小分子抑制剂，或预防和/或治疗与ASK1相关疾病，尤其是肝脏疾病、肺部疾病、心血管疾病、肾脏疾病和代谢性疾病的药物中的用途。